Lucy Harutyunyan, Hematologist, R1 Researcher at Yeolyan Hematology and Oncology Center, Ministry of Health of Armenia, and Adjunct Researcher at Immune Oncology Research Institute, shared a post on LinkedIn:
“Sharing Our Latest Work on BPDCN
Together with my supervisor Astghik Voskanyan and our dedicated team, we evaluated allo-SCT outcomes in patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Our promising data was presented at ASH 2025.
For collaboration opportunities, please feel free to reach out.”
Title: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) international registry: Assessment of the allo-HCT outcomes
Authors: Lusine Harutyunyan, Marina Konopleva, Maria Badikyan, Alvaro Alencar, Arusyak Ivanyan, Carolyn Owen, Ching-Tien Peng, Dickran Kazandjian, Funda Tekkesin, Justin Taylor, Hasanein Ghali, Hasmik Maghaqyan, Karen Bedirian, Maria Paola Martelli, Enrico Attardi, Maria Teresa Voso, Mariam Abramashvili, Mazin Faisal Al-Jadiry, Michalis Michael, Min-Yu Su, Astghik Voskanyan
Read the Full Article.
More posts featuring Lucy Harutyunyan.